NSNatalija Smetanina

Natalija Smetanina

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Natalija Smetanina has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Prevalence of Metabolic Syndrome and Impaired Glucose Metabolism among 10- to 17-Year-Old Overweight and Obese Lithuanian Children and Adolescents

    by Natalija Smetanina, Raimondas Valickas, Astra Vitkauskiene, Kerstin Albertsson-Wikland, Rasa Verkauskienė

    Background: Overweight (Ow) and obesity among adults and children increases the risk of metabolic consequences. Metabolic syndrome (MS) and impaired glucose metabolism are well-known risk factors for cardiovascular diseases and type 2 diabetes. The aim of this study was to evaluate the prevalence of MS and impaired glucose metabolism among Ow and obese (Ob) children and adolescents (aged 10–17 years) in Lithuania, and to evaluate the associations between insulin resistance (IR) indices and anthropometric parameters as well as metabolic disturbances. Methods: The study population consisted of 344 OwOb children and adolescents of all pubertal stages. Oral glucose tolerance tests (OGTTs), IR and β cell function indices, lipid profile, and anthropometric parameters of all subjects were analyzed. MS was defined according to the International Diabetes Federation consensus guidelines. Results: MS was found in 21.3% of the OwOb children and adolescents, and 12.1% had impaired glucose metabolism (6.9% with impaired fasting glucose, 4.5% with impaired glucose tolerance, and 0.6% with type 2 diabetes). IR was directly related to body mass index and waist circumference, waist-to-height and waist-to-hip ratios, and sum of skin-fold thicknesses. Children with MS were more insulin-resistant, had higher odds ratio for prediabetes and had a more disturbed lipid profile than subjects without MS. Moreover, total cholesterol and low-density lipoprotein cholesterol levels were significantly lower in the more mature OwOb adolescents. Conclusion: MS and lipid profile disturbances are common in OwOb children and adolescents. MS is directly associated with IR. Therefore, OwOb children and adolescents should be carefully followed up for metabolic abnormalities during late childhood as these can persist into adulthood.


  • Open Access

    Prevalence of overweight/obesity in relation to dietary habits and lifestyle among 7–17 years old children and adolescents in Lithuania

    by Natalija Smetanina, Edita Albaviciute, Veslava Babinska, Lina Karinauskiene, Kerstin Albertsson-Wikland, Ausra Petrauskiene, Rasa Verkauskiene

    Until recently increasing prevalence of overweight and obesity among pediatric population in Europe and worldwide contributes to major well-known risks for metabolic consequences in later life. The aim of this study was to determine the prevalence of overweight/obesity among children and adolescents in Lithuania and assess its association with energy balance related behaviors as well as familial demographic and socioeconomic factors. Cross-sectional study included 3990 7–17 years old schoolchildren from 40 schools of Kaunas region, Lithuania. Study participants underwent anthropometric measurements. Body mass index (BMI) was evaluated according to International Obesity Task Force (IOTF) criteria for children and adolescents. Children and adolescents and their parents filled in the questionnaires on parental sociodemographic characteristics, dietary habits, TV watching time, and family socioeconomic status. The prevalence of underweight, overweight, and obesity among boys and girls was 6.9 and 11.7 % (P < 0.05), 12.6 and 12.6 % (P > 0.05), and 4.9 and 3.4 % (P < 0.05), respectively. Obesity was significantly more prevalent in the 7–9 years old group (6.7 and 4.8 % in boys and girls, respectively, P < 0.05). Lower meals frequency and breakfast skipping were directly associated with overweight/obesity (P < 0.05); however, physical inactivity was not associated with higher BMI. Children‘s overweight/obesity was directly associated with lower paternal education and unemployment (OR 1.30, P = 0.013 and OR 1.56, P = 0.003, respectively). The prevalence of overweight and obesity among 7–17 years old Lithuanian children and adolescents was more prevalent in younger age, still being one of the lowest across the European countries. Meals frequency, breakfast skipping, paternal education and unemployment as well as a family history of arterial hypertension were found to be associated with children’s and adolescents’ overweight/obesity.


  • Population-based cohort study: PROP1 gene mutations are the most prevalent cause of congenital multiple pituitary hormone deficiency in Lithuania

    by Ruta Navardauskaite, Petra Dusatkova, Barbora Obermannova, Roland W Pfaeffle, Werner F Blum, Dalia Adukauskiene, Natalija Smetanina, Ondrej Cinek, Rasa Verkauskiene, Jan Lebl

    Introduction: Congenital multiple pituitary hormone deficiency (MPHD) may result from defects of transcription factors that govern the early pituitary development. The most prevalent are two mutation of PROP1 gene: the c.296delGA and c.150delA. Methods: Seventy-five Lithuanian MPHD patients were tested for PROP1 defects. Perinatal and postnatal data were obtained from medical records. Hormonal investigations, pituitary imaging and GH therapy were performed at a single centre in Kaunas. The PROP1 gene was investigated by Sanger sequencing. Ancestral origin of mutation was assessed by genotyping of 22 single nucleotide polymorphisms flanking the PROP1 gene, and their haplotype analysis. Results: Fifty-two subjects (69.3%; 28 males; including ten sibling pairs and two sibling triples) from 38 families were found to carry a biallelic PROP1 gene mutation. Fifty of these were homozygous 296delGA and two were compound heterozygotes 296delGA/R71H and 296delGA/150delA. We found the highest rate of PROP1 mutations among MPHD patients from populations studied so far (17.5 per million). Patients’ birth lengths/weights were normal. Height declined to S.D. −1.56, −2.34, −3.43, −3.52, and −3.70 (medians) at years 1–5. Deficiencies of GH, TSH, ACTH, and FSH/LH were diagnosed in 50/52, 52/52, 21/52, and 25/52 subjects at median age 5.5; 5.6; 13.1, and 15.0 years respectively. Pituitary height ranged from 16.6 (+20.2 S.D.) to 1.4 mm (−15.5 S.D.) and declined with age (r2=0.27, P=0.001). GH therapy increased growth rates to 12.2; 9.1; 6.9; 6.8; 6.7; 5.6, and 5.7 cm/year (medians). The mutation carriers were found to share a common ancestor with the c.296delGA mutation having arisen about 112 generations ago (P≤3×10−4). Conclusions: The population-based cohort of patients with PROP1 gene mutation is the largest described so far. High prevalence of PROP1 defects in Lithuania is due to a founder effect of c.296delGA mutation.